Telomerase activity in melanocytic lesions: A potential marker of tumor biology

American Journal of Pathology

Volumn 156, Issue 4, 2000, Pages 1425-1432

  Rudolph, Pierre ^a   Schubert, Christoph ^b   Tamm, Sontka ^a   Heidorn, Klaus ^a   Hauschild, Axel ^a   Michalska, Iwona ^c   Majewski, Slavomir ^c   Krupp, Guido ^a   Jablonska, Stephania ^c   Parwaresch, Reza ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Institute of Dermatopathology   (Germany)

^c UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; TELOMERASE;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOMA; METASTASIS; NEVUS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033847898     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65011-0     Document Type: Article

References (73)

1. Telomeres shorten during ageing of human fibroblasts
2. Telomere length predicts replicative capacity of human fibroblasts
3. Origin of concatemeric T7 DNA
4. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon
5. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age
6. Longevity, stress response, and cancer in aging telomerase-deficient mice
7. Recognition and elongation of telomeres by telomerase
8. Telomerases
9. Regulation of telomerase activity in immortal cell lines
10. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
11. Telomere length regulation
12. Telomerase in human development and cancer
13. Telomerase in cancer: Clinical applications
14. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues
15. Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions
16. Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma
17. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas
18. Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis
19. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues
20. Detection of ovarian cancer cells: Comparison of a telomerase assay and cytologic examination
21. Telomerase assays in the diagnosis and prognosis of cancer
22. Telomerase activity in human germline and embryonic tissues and cells
23. Loss of telomerase activity during male germ cell differentiation
24. Telomerase activity in gastric cancer
25. Telomerase activity in benign endometrium and endometrial carcinoma
26. Analysis of telomerase expression and proliferative activity in the different layers of cyclic endometrium
27. Telomeres and telomerase in human leukemias
28. Telomerase activity in normal and malignant hematopoietic cells
29. Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes
30. Telomerase activity in normal human epithelial cells
31. Telomerase activity concentrates in the mitotically active segments of human hair follicles
32. Evidence for UV-associated activation of telomerase in human skin
33. Detection of telomerase activity in malignant and nonmalignant skin conditions
34. Telomerase activity in radiation-induced chronic human skin ulcers
35. Prognostic relevance of a novel proliferation marker, Ki-S11, for soft tissue sarcoma. A multivariate study
36. Enhanced expression of Ki-67, topoisomerase II alpha, PCNA, p53 and p21(WAF1/Cip1) reflecting proliferation and repair activity in UV-irradiated melanocytic nevi
37. The immunohistochemical marker Ki-S2: Tissue distribution and cell cycle kinetics of a novel proliferation-specific antigen
38. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
39. 2, and M
40. The dysplastic nevus
41. Histopathologic diagnosis of dysplastic nevi: Concordance among pathologists convened by the World Health Organization melanoma programme
42. Molecular basis of artifacts in the detection of telomerase activity and a modified primer for a more robust 'TRAP' assay
43. Regulation of telomerase activity in quiescent immortalized human cells
44. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity
45. Moist autoclaving. A simplified method for antigen unmasking
46. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi
47. Atypical mole syndrome: Risk factor for cutaneous malignant melanoma and implications for management
48. Benign melanocytic lesions: Risk markers or precursors of cutaneous melanoma?
49. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma
50. Atypical Mole: Dysplastic Nevus or Typical Myth?
51. Benign atypical naevi: Diagnostic difficulties and continued controversy
52. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
53. Telomerase activity in human cancer
54. Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions
55. Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions
56. Telomerase activity is elevated in early S phase in hamster cells
57. Cell cycle-dependent modulation of telomerase activity in tumor cells
58. Telomerase activity: A biomarker of cell proliferation, not malignant transformation
59. Specific association of human telomerase activity with immortal cells and cancer
60. Telomerase activity, cell proliferation, and cancer
61. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype
62. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas
63. Dysplastic nevus syndrome: A phenotypic association of sporadic cutaneous melanoma
64. Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome
65. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma
66. Risk of developing cutaneous malignant melanoma in atypical-mole syndrome: New York University experience and literature review
67. A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
68. The early and intermediate precursor lesions of tumor progression in the melanocytic system: Common acquired nevi and atypical (dysplastic) nevi
69. The presence of dysplastic nevus remnants in malignant melanomas
70. Pathology of malignant melanoma, including new markers and techniques in diagnosis and prognosis
71. Comparison of two prognostic models predicting survival in patients with malignant melanoma